News & Announcements
In this Q&A, David Fryburg, M.D.,Chair of the Beta Cell Project Team, discusses the results of this significant project as it comes to a close.
The Lung Cancer Master Protocol (Lung-MAP) is undergoing a major expansion to include patients with all non-small cell lung cancers.
The FNIH Board of Directors elected distinguished scientific leader, Dr. Zerhouni, as its newest member. His appointment took effect on January 1, 2019.
Spotlight
FNIH Biomarkers Consortium and Critical Path Institute achieve the first ever qualification of a clinical safety biomarker by the U.S. Food and Drug Administration.
Learn how the AMP RA/Lupus project is helping patients with rheumatoid arthritis and lupus.
The FNIH is delighted to once again earn the highest, 4-star rating from Charity Navigator.